After initiating combined hormonal contraception, patients should be counseled to monitor for which warning signs?

Prepare for the NAPLEX Contraception and Infertility Test. Engage with interactive flashcards and multiple choice questions, each equipped with hints and explanations. Ensure your readiness for the exam!

Multiple Choice

After initiating combined hormonal contraception, patients should be counseled to monitor for which warning signs?

Explanation:
Estrogen-containing combined hormonal contraception increases the risk of venous thromboembolism, so patients must watch for signs that a clot could be forming or traveling to the lungs or brain. The most critical warning signs are unilateral leg swelling with pain or warmth (suggesting deep vein thrombosis), chest pain or new or worsening shortness of breath (suggesting pulmonary embolism), and a sudden severe headache with focal neurological symptoms (suggesting a stroke). Other symptoms like mild fatigue, itchy skin, or general weight gain are nonspecific and not reliable indicators of a clot, though any new or concerning symptoms should be discussed with a clinician. If any warning signs occur, discontinue the contraception and seek urgent medical evaluation to assess for VTE.

Estrogen-containing combined hormonal contraception increases the risk of venous thromboembolism, so patients must watch for signs that a clot could be forming or traveling to the lungs or brain. The most critical warning signs are unilateral leg swelling with pain or warmth (suggesting deep vein thrombosis), chest pain or new or worsening shortness of breath (suggesting pulmonary embolism), and a sudden severe headache with focal neurological symptoms (suggesting a stroke). Other symptoms like mild fatigue, itchy skin, or general weight gain are nonspecific and not reliable indicators of a clot, though any new or concerning symptoms should be discussed with a clinician. If any warning signs occur, discontinue the contraception and seek urgent medical evaluation to assess for VTE.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy